Melbourn, United Kingdom

Michael Noble

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Noble: Innovator in Diagnostic Testing

Introduction

Michael Noble is a distinguished inventor based in Melbourn, GB. He has made significant contributions to the field of diagnostic testing, holding 2 patents that focus on innovative methods and devices for measuring analytes in physiological fluids.

Latest Patents

Noble's latest patents include "Devices and methods for testing analytes" and "Devices and methods for measurement of sample properties." The first patent provides a method and device for measuring clinically relevant analytes, such as glucose, in fluids like blood. This device features a flow path for conducting the fluid, a detection chamber, and detector means to assess analyte levels. The detection chamber contains a predetermined amount of an analyte that mixes with the fluid to create a calibration sample, allowing for accurate measurements at different times. The second patent offers a flexible format for diagnostic tests applicable to a wide range of fluid properties. It involves creating a concentration gradient of an indicator in the sample and measuring its flux to determine the sample's properties.

Career Highlights

Michael Noble has established himself as a key figure in the field of diagnostic innovation. His work at Pa Knowledge Limited has allowed him to develop groundbreaking technologies that enhance the accuracy and efficiency of diagnostic testing.

Collaborations

Noble collaborates with Mark Robson Humphries, contributing to the advancement of diagnostic technologies through their combined expertise.

Conclusion

Michael Noble's contributions to diagnostic testing through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the field and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…